UnitedHealth Group (UNH) Stock Declines While Market Improves: Some Information for Investors
Werte in diesem Artikel
In the latest trading session, UnitedHealth Group (UNH) closed at $300.38, marking a -0.28% move from the previous day. This change lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow lost 0.22%, while the tech-heavy Nasdaq added 0.32%.The largest U.S. health insurer's stock has dropped by 23.65% in the past month, falling short of the Medical sector's loss of 2.72% and the S&P 500's gain of 5.2%.Investors will be eagerly watching for the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 29, 2025. The company's upcoming EPS is projected at $5.25, signifying a 22.79% drop compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $112.14 billion, indicating a 13.44% increase compared to the same quarter of the previous year.For the annual period, the Zacks Consensus Estimates anticipate earnings of $22.88 per share and a revenue of $450.15 billion, signifying shifts of -17.28% and +12.46%, respectively, from the last year.Investors should also pay attention to any latest changes in analyst estimates for UnitedHealth Group. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 13.59% decrease. As of now, UnitedHealth Group holds a Zacks Rank of #5 (Strong Sell).From a valuation perspective, UnitedHealth Group is currently exchanging hands at a Forward P/E ratio of 13.16. Its industry sports an average Forward P/E of 13.16, so one might conclude that UnitedHealth Group is trading at no noticeable deviation comparatively.We can also see that UNH currently has a PEG ratio of 1.2. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 0.96 as of yesterday's close.The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 91, positioning it in the top 37% of all 250+ industries.The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: UnitedHealth und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf UnitedHealth
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf UnitedHealth
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu UnitedHealth Inc.
Analysen zu UnitedHealth Inc.
Datum | Rating | Analyst | |
---|---|---|---|
14.04.2022 | UnitedHealth Outperform | RBC Capital Markets | |
15.10.2020 | UnitedHealth Outperform | Credit Suisse Group | |
14.10.2020 | UnitedHealth Outperform | RBC Capital Markets | |
29.08.2019 | UnitedHealth Outperform | Credit Suisse Group | |
17.07.2018 | UnitedHealth buy | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
14.04.2022 | UnitedHealth Outperform | RBC Capital Markets | |
15.10.2020 | UnitedHealth Outperform | Credit Suisse Group | |
14.10.2020 | UnitedHealth Outperform | RBC Capital Markets | |
29.08.2019 | UnitedHealth Outperform | Credit Suisse Group | |
17.07.2018 | UnitedHealth buy | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
09.11.2016 | UnitedHealth Group Neutral | Mizuho | |
31.03.2011 | UnitedHealth Group perform | Oppenheimer & Co. Inc. | |
08.02.2011 | UnitedHealth Group neutral | Goldman Sachs Group Inc. | |
15.11.2010 | UnitedHealth Group hold | Stifel, Nicolaus & Co., Inc. | |
20.04.2010 | UnitedHealth neutral | Wedbush Morgan Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
11.06.2009 | UnitedHealth underperform | Oppenheimer & Co. Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UnitedHealth Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen